CryoPort Inc (CYRX)

[Rev3lation]

$5.50 new price Target by Cowen

CryoPort initiated with a Outperform at Cowen; tgt $5.50
Briefing.com

"Cowen initiates CYRX with a Outperform and price target of $5.50. As a leading logistics provider to the biopharma market, CYRX is well positioned to benefit from the likely approval of KITE's and NVS's CAR T therapies currently being reviewed by the FDA. July 12th is the next catalyst for the stock, in firm's view. They see revenue ramping, an improving cash flow profile and expanding margins in 2018."